Novel use of peptide compounds for treating pain in trigeminal neuralgia

Details for Australian Patent Application No. 2005251465 (hide)

Owner Schwarz Pharma AG

Inventors Rauschkolb-Loffler, Christine; Stohr, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2005251465

PCT Pub. Number WO2005/120539

Priority 60/578,062 09.06.04 US; 04013635.0 09.06.04 EP

Filing date 9 June 2005

Wipo publication date 22 December 2005

Acceptance publication date 9 July 2009

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/120539 Priority application(s): WO2005/120539

9 July 2009 Application Accepted

  Published as AU-B-2005251465

5 November 2009 Standard Patent Sealed

16 December 2010 Alteration of Name

  The name of the patentee has been altered to UCB Pharma GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005251468-Method of applying pesticides

2005251463-Anti-cancer composition comprising proline or its derivatives and an antitumour antibody